Overview
Price
Price
Daxor Corporation (Nasdaq: DXR) is the global leader in blood volume measurement technology focused on blood volume testing innovation. We developed and market the BVA-100® (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms. The BVA technology enhances hospital performance metrics in a broad range of surgical and medical conditions, including heart failure and critical care, by informing treatment strategies, resulting in significantly improved multiple measures of patient outcomes. Daxor’s mission is to advance healthcare by enabling optimal fluid management with blood volume analysis. Daxor’s vision is optimal blood volume for all.
Price History
Company Profile
107 Meco Lane,
Oak Ridge, TN 37830
(865) 425-0555
info@daxor.com
News
Daxor CEO Michael Feldschuh Reports First Half 2022 Financial Results
Watch Daxor CEO, Michael Feldschuh, Discuss How BVA-100 Technology is Joining to Fight COVID-19
Watch Daxor CEO, Michael Feldschuh, Talk About The Importance of Blood Volume Testing
Watch Daxor CEO, Michael Feldschuh, Discuss How BVA Technology is Reimagining the Industry
Watch How BVA Positively Impacts Lives
Watch Daxor CEO, Michael Feldschuh, Discuss How BVA-100 Technology is Joining to Fight COVID-19
Watch Daxor CEO, Michael Feldschuh, Talk About The Importance of Blood Volume Testing
Watch Daxor CEO, Michael Feldschuh, Discuss How BVA Technology is Reimagining the Industry
In the Spotlight
BioTuesdays:
Daxor targeting blood volume analysis to reduce mortality and ventilator use in ICU
MedGadget:
Blood Volume Analysis Using The BVA-100: Interview with Michael Feldschuh, Daxor CEO
Healio:
Blood Volume Analysis May Help Guide Treatment in HF Hospitalization at Low Cost
Technology
Networks:
Daxor Corporation Announces Phase-Two US Air Force Contract Award for Point-Of-Care Optical Blood Volume Analyzer
Investor Relations
Bret Shapiro
CORE IR
377 Oak Street
Garden City, NY 11530
Phone: 516-222-2560
E-mail: brets@coreir.com
www.coreir.com
Transfer Agent
Continental Stock Transfer
1 State Street, 30th Floor
New York, NY 10004
Phone: 212-509-4000
E-mail: cstmail@continentalstock.com
www.continentalstock.com
Auditors
Steven Zelin & Associates, CPA, LLC
555 Eighth Avenue, Suite 2203
New York, NY 10018
Phone: 646-678-4496
Email: Steven.zelin@zelincpa.com
Corporate Counsel
Peter Fetzer
Foley & Lardner LLP
777 East Wisconsin Avenue
Milwaukee, Wisconsin 53202
Phone: 414-271-2400
Fax: 414-297-4900
www.foley.com
Partner With the Dedicated Leader in BVA
As the pioneer in blood volume analysis, Daxor provides education and the resources needed to ensure easy onboarding along with continuing support to drive maximum value from your BVA system throughout your facility. With a long-standing commitment to improving care and numerous studies validating our technology, Daxor is completely focused on advancing healthcare by enabling optimal fluid management with blood volume analysis. Our vision is optimal blood volume for all.
Volume is Vital. End the Debate With Daxor.
Call us at 865-425-0555.
Daxor Corporation is the global leader in blood volume measurement technology focused on blood volume testing innovation. We developed and market the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for use in a broad range of medical and surgical conditions.
Daxor Corporation – 107 Meco Lane, Oak Ridge, TN 37830
Phone: 865-425-0555 | Fax: 865-425-0551
info@daxor.com | daxor.com
ISO 13485 Certified
Made in the USA.
COPYRIGHT 2023 © DAXOR CORPORATION – ALL RIGHTS RESERVED.